Exposure of Mesenchymal Stem Cells to an Alzheimer's Disease Environment Enhances Therapeutic Effects

• Prif Awduron: Sang Eon Park (Awdur), Hyeong Seop Kim (Awdur), Soo Jin Kwon (Awdur), Min-Jeong Kim (Awdur), Suk-joo Choi (Awdur), Soo-young Oh (Awdur), Gyu Ha Ryu (Awdur), Hong Bae Jeon (Awdur), Duk L. Na (Awdur), Jong Wook Chang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Hindawi Limited, 2021-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Mesenchymal stem cells (MSCs) have emerged as a promising tool for the treatment of Alzheimer's disease (AD). Previous studies suggested that the coculture of human MSCs with AD in an in vitro model reduced the expression of amyloid-beta 42 (Aβ42) in the medium as well as the overexpression of...